Hemolytic Uremic Syndrome: Symptoms, Treatment Options and Prognosis

Glenna Clayton (Editor)

Series: Renal, Metabolic and Urologic Disorders
BISAC: MED088000



Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick


Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:



Hemolytic uremic syndrome (HUS) is characterized by the triad non-immune micro-angiopathic hemolytic anemia, thrombocytopenia and acute renal failure. The disease mainly affects children one to ten years of age. It begins after an incubation period of 4 to 7 days with abrupt onset of bloody diarrhea and abdominal pain. Two to ten days later, microangiopathy, haemolytic anaemia, thrombocytopenia, and acute renal failure develop. HUS microangiopathy can involve almost any organ, but damage to kidneys and central nervous system cause the most severe clinical problems. This book discusses the symptoms, the treatment options and prognosis of HUS.
(Imprint: Nova Biomedical)


Chapter 1 - The Role of Thrombin in Hemolytic Uremic Syndrome and Other Thrombotic Microangiopathies (pp. 1-28)
William Nicholas Rose, Kenneth D. Friedman and Thomas J. Raife (Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA, and others)

Chapter 2 - Therapeutic Apheresis in Children with Renal Diseases, Especially Hemolytic Uremic Syndrome (pp. 29-74)
Rolf Bambauer, Daniel Burgard and Ralf Schiel (Formerly: Institute for Blood Purification, Homburg, Germany, and others)

Chapter 3 - The Consequences of Soliris® Therapy in Patients with aHUS (pp. 75-92)
Karin Janssen van Doorn (Nephrology Department, University Hospital Antwerp, Belgium)

Chapter 4 - Hemolytic Uremic Syndrome: Overview and Update (pp. 93-108)
Naglaa Michel Habib Keriakos and Rami N. Khouzam (University of Tennessee Health Science Center, Memphis, TN and others)


You have not viewed any product yet.